Analysen zu Prosus N.V.
| 28.11.23 | Prosus Overweight | JP Morgan Chase & Co. | |
| 22.11.23 | Prosus Buy | UBS AG | |
| 21.11.23 | Prosus Buy | Deutsche Bank AG | |
| 21.11.23 | Prosus Buy | Goldman Sachs Group Inc. | |
| 10.11.23 | Prosus Overweight | JP Morgan Chase & Co. | |
| 03.11.23 | Prosus Buy | Goldman Sachs Group Inc. | |
| 10.10.23 | Prosus Overweight | Barclays Capital | |
| 29.09.23 | Prosus Buy | Goldman Sachs Group Inc. | |
| 25.09.23 | Prosus Overweight | JP Morgan Chase & Co. | |
| 15.09.23 | Prosus Buy | Deutsche Bank AG | |
| 08.09.23 | Prosus Buy | UBS AG | |
| 08.09.23 | Prosus Buy | UBS AG | |
| 18.08.23 | Prosus Buy | UBS AG | |
| 18.08.23 | Prosus Overweight | JP Morgan Chase & Co. | |
| 18.08.23 | Prosus Overweight | Barclays Capital | |
| 05.07.23 | Prosus Buy | Deutsche Bank AG | |
| 30.06.23 | Prosus Outperform | Credit Suisse Group | |
| 28.06.23 | Prosus Buy | UBS AG | |
| 28.06.23 | Prosus Buy | Deutsche Bank AG | |
| 28.06.23 | Prosus Overweight | JP Morgan Chase & Co. | |
| 28.06.23 | Prosus Hold | Jefferies & Company Inc. | |
| 27.06.23 | Prosus Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.06.23 | Prosus Buy | UBS AG | |
| 27.06.23 | Prosus Hold | Jefferies & Company Inc. | |
| 15.06.23 | Prosus Buy | UBS AG | |
| 13.06.23 | Prosus Buy | UBS AG | |
| 08.06.23 | Prosus Equal Weight | Barclays Capital | |
| 07.06.23 | Prosus Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.05.23 | Prosus Overweight | JP Morgan Chase & Co. | |
| 24.04.23 | Prosus Buy | UBS AG | |
| 19.04.23 | Prosus Buy | UBS AG | |
| 11.04.23 | Prosus Overweight | JP Morgan Chase & Co. | |
| 06.04.23 | Prosus Equal Weight | Barclays Capital | |
| 04.04.23 | Prosus Overweight | JP Morgan Chase & Co. | |
| 24.03.23 | Prosus Overweight | JP Morgan Chase & Co. | |
| 24.03.23 | Prosus Buy | UBS AG | |
| 03.03.23 | Prosus Buy | UBS AG | |
| 02.03.23 | Prosus Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.02.23 | Prosus Buy | UBS AG | |
| 22.02.23 | Prosus Buy | UBS AG | |
| 06.02.23 | Prosus Conviction Buy List | Goldman Sachs Group Inc. |
Aktuelle Aktienanalysen
| 07.02.25 | BP Underweight | JP Morgan Chase & Co. | |
| 07.02.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 07.02.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 07.02.25 | KION GROUP Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.02.25 | Porsche Neutral | UBS AG | |
| 07.02.25 | Deutsche Börse Sector Perform | RBC Capital Markets | |
| 07.02.25 | Amazon Buy | Goldman Sachs Group Inc. | |
| 07.02.25 | Adyen B.V. Parts Sociales Overweight | JP Morgan Chase & Co. | |
| 07.02.25 | Siemens Healthineers Overweight | Barclays Capital | |
| 07.02.25 | Novo Nordisk Buy | UBS AG | |
| 07.02.25 | Under Armour Underweight | JP Morgan Chase & Co. | |
| 07.02.25 | ArcelorMittal Neutral | Goldman Sachs Group Inc. | |
| 07.02.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 07.02.25 | RATIONAL Verkaufen | DZ BANK | |
| 07.02.25 | Siemens Healthineers Overweight | JP Morgan Chase & Co. | |
| 07.02.25 | Under Armour Buy | UBS AG | |
| 07.02.25 | VINCI Buy | Goldman Sachs Group Inc. | |
| 07.02.25 | Stellantis Buy | Goldman Sachs Group Inc. | |
| 07.02.25 | L'Oréal Buy | Goldman Sachs Group Inc. | |
| 07.02.25 | Porsche Buy | Goldman Sachs Group Inc. | |
| 07.02.25 | WACKER CHEMIE Neutral | JP Morgan Chase & Co. | |
| 07.02.25 | K+S Neutral | JP Morgan Chase & Co. | |
| 07.02.25 | Evonik Overweight | JP Morgan Chase & Co. | |
| 07.02.25 | LANXESS Underweight | JP Morgan Chase & Co. | |
| 07.02.25 | BASF Neutral | JP Morgan Chase & Co. | |
| 07.02.25 | BNP Paribas Buy | Goldman Sachs Group Inc. | |
| 07.02.25 | ING Group Neutral | Goldman Sachs Group Inc. | |
| 07.02.25 | Nordex Buy | Goldman Sachs Group Inc. | |
| 07.02.25 | Allianz Buy | Goldman Sachs Group Inc. | |
| 07.02.25 | DocMorris Sell | UBS AG | |
| 07.02.25 | Amazon Buy | Goldman Sachs Group Inc. | |
| 07.02.25 | Amazon Buy | UBS AG | |
| 06.02.25 | Porsche Hold | Jefferies & Company Inc. | |
| 06.02.25 | L'Oréal Market-Perform | Bernstein Research | |
| 06.02.25 | RATIONAL Outperform | Bernstein Research | |
| 06.02.25 | VINCI Buy | UBS AG | |
| 06.02.25 | Nike Neutral | UBS AG | |
| 06.02.25 | L'Oréal Neutral | UBS AG | |
| 06.02.25 | L'Oréal Underweight | JP Morgan Chase & Co. | |
| 06.02.25 | Nike Neutral | JP Morgan Chase & Co. | |
| 06.02.25 | Porsche Overweight | JP Morgan Chase & Co. | |
| 06.02.25 | VINCI Overweight | JP Morgan Chase & Co. | |
| 06.02.25 | Adyen B.V. Parts Sociales Buy | Jefferies & Company Inc. | |
| 06.02.25 | VINCI Outperform | RBC Capital Markets | |
| 06.02.25 | Nike Sector Perform | RBC Capital Markets | |
| 06.02.25 | L'Oréal Hold | Jefferies & Company Inc. | |
| 06.02.25 | L'Oréal Sector Perform | RBC Capital Markets | |
| 06.02.25 | London Stock Exchange Buy | UBS AG | |
| 06.02.25 | Intesa Sanpaolo Buy | UBS AG | |
| 06.02.25 | Intel Verkaufen | DZ BANK |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.